During the COVID-19 pandemic, we found a decrease in the exclusion of older adults from vaccine trials but no significant change in the inclusion of immunocompromised individulas.
No takes yet. Share an insight, caveat, or question.
Bukan et al. (2023) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: